Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 492 of 1,261
  1. US 10316073

    FCRN antagonists and methods of use

    The Board of Regents of the University of Texas System · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted
  2. US 10314850

    Use of ACTH in assessment and prophylactic treatment of hypokalemia associated with glucocorticoid receptor modulator treatment of Cushing's syndrome patients

    Corcept Therapeutics Incorporated · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted
  3. US 10315984

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted
  4. US 10316371

    Screening methods for identifying specific Staphylococcus aureus inhibitors

    TRANA DISCOVERY, INC. · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted
  5. US 10314837

    Subcutaneous delivery of poly(oxazoline) polymer conjugates

    Serina Therapeutics, Inc. · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted
  6. US 10314860

    Compositions and methods for treating and preventing venom related poisoning

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted
  7. US 10314769

    Organic-inorganic composite particles and cosmetic product

    JGC Catalysts and Chemicals Ltd. · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted
  8. US 10314790

    Sustained-release formulations of topiramate

    Supernus Pharmaceuticals, Inc. · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted
  9. US 10314810

    Aryl hydrocarbon receptor (AhR) modifiers as novel cancer therapeutics

    Northwestern University · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted
  10. US 10314819

    Solid state forms of Eluxadoline

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted
  11. US 10314818

    Salinosporamides and methods of use thereof

    The Regents of the University of California · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted
  12. US 10314824

    Compositions and methods of treating cardiac fibrosis with ifetroban

    Cumberland Pharmaceuticals Inc. · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted
  13. US 10314891

    Method for delivering pramlintide into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted
  14. US 10316316

    Compositions for targeted delivery of siRNA

    Arrowhead Pharmaceuticals, Inc. · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted
  15. US 10316105

    Anti-TIE2 antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted
  16. US 10316318

    Oligonucleotide compositions and uses thereof

    MIRAGEN THERAPEUTICS, INC. · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted
  17. US 10316289

    Methods of producing T memory stem cell populations

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted
  18. US 10316368

    Altered microbiome of chronic pelvic pain

    Northwestern University · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted
  19. US 10316080

    Protein-polymer-drug conjugates

    Asana BioSciences, LLC · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted
  20. US 10316050

    PT (IV) complexes containing 4,4′-disubstituted-2,2′-bipyridyl and their use in cancer therapy

    THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted
  21. US 10316038

    Pyrrolopyrimidine ITK inhibitors for treating inflammation and cancer

    Aclaris Therapeutics, Inc. · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted
  22. US 10316348

    Diagnostic system and process for rapid bacterial infection diagnosis

    Northwestern University · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted
  23. US 10316039

    P2X3 and/or P2X2/3 compounds and methods

    Asana BioSciences, LLC · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted
  24. US 10316031

    Compositions and methods for inhibiting kinases

    Inhibikase Therapeutics, Inc. · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.